March 21, 2018
FDA: 5 Things to Know About Breast Implants
Should I get breast implants? Are there alternatives? Will they need to be replaced? And if I decide to get…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
March 21, 2018
Sobi launches Ravicti in Europe and advances the care for patients with Urea Cycle Disorders
Swedish Orphan Biovitrum has gained reimbursement for Ravicti, a new therapy option for the treatment of patients with Urea Cycle…
March 20, 2018
Fifth FDA-approved indication for Adcetris changes four decades old way to treat Hodgkin lymphoma
The U.S. Food and Drug Administration on Tuesday approved Saettle Genetics’s Adcetris (brentuximab vedotin) to treat adult patients with previously…
March 20, 2018
Mylan launches Mitomycin, generic cancer drug version of BMS’s Mutamycin
Mylan N.V. has launched its generic version of BMSs oncology drug Mutamycin in USA, called Mitomycin, for which it noted…
March 20, 2018
Novartis teams up with Harvard to develop next generation biomaterial systems to deliver immunotherapies
Novartis has teamed up with scientists from the Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber…
March 20, 2018
Hikma launches Ritonavir Tablets USP
Hikma Pharmaceuticals’s wholly owned US subsidiary West-Ward Pharmaceuticals, has launched Ritonavir Tablets USP, 100 mg, the first AB-rated generic to…
March 19, 2018
BD strips remaining stake in Vyaire Medical for $435 million
BD said Monday today it will divest its remaining, minority stake in Vyaire Medical to funds managed by Apax Partners for $435…
March 19, 2018
Cidara Therapeutics might have once-weekly treatment option for patients with difficult-to-treat and deadly invasive Candida infections
The results reported by Cidara Therapeutics, for its lead antifungal candidate rezafungin acetate, which met all of its primary objectives,…
March 19, 2018
Boehringer Ingelheims’ snintedanib for treatment of a type of systemic sclerosis gets fast tracked by the FDA
Boehringer Ingelheim’s nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease (SSc-ILD), has been put to the fast…
March 19, 2018
Baxter broadens its surgical hemostat and sealand portfolio with Recothrom and Preveleak acquisition
Baxter International has completed the acquisition of two hemostat and sealant products from Mallinckrodt plc. RECOTHROM Thrombin topical (Recombinant) is…